Sixty seconds on . . . digitalisation of pharmaBMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2329 (Published 29 May 2018) Cite this as: BMJ 2018;361:k2329
- Ann Robinson
- London, UK
What’s that, then?
It’s the new way to make drugs. Manufacturers, including the pharmaceutical industry, are increasingly automating production. Computers continually analyse multiple variables, predict errors, use machine learning to improve systems, and allow products to be modified. The aim of this “process analysis technology” is to get drug production right first time.
Surely drug production is already highly automated?
You’d be surprised. Take chimeric antigen receptor T cells; a novel form of immunotherapy offering potentially …